List of Tables
Table 1. Nuclear Radiopharmaceutical Market Trends
Table 2. Nuclear Radiopharmaceutical Market Drivers & Opportunity
Table 3. Nuclear Radiopharmaceutical Market Challenges
Table 4. Nuclear Radiopharmaceutical Market Restraints
Table 5. Global Nuclear Radiopharmaceutical Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Nuclear Radiopharmaceutical Revenue Market Share by Company (2019-2024)
Table 7. Global Nuclear Radiopharmaceutical Sales Volume by Company (2019-2024) & (Units)
Table 8. Global Nuclear Radiopharmaceutical Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Nuclear Radiopharmaceutical Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Nuclear Radiopharmaceutical Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Nuclear Radiopharmaceutical Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Nuclear Radiopharmaceutical
Table 13. Global Nuclear Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Radiopharmaceutical as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Nuclear Radiopharmaceutical Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Nuclear Radiopharmaceutical Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Nuclear Radiopharmaceutical Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Nuclear Radiopharmaceutical Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Nuclear Radiopharmaceutical Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Nuclear Radiopharmaceutical Sales Volume by Type: 2019 VS 2023 VS 2030 (Units)
Table 22. Global Nuclear Radiopharmaceutical Sales Volume by Type (2019-2024) & (Units)
Table 23. Global Nuclear Radiopharmaceutical Sales Volume by Type (2025-2030) & (Units)
Table 24. Global Nuclear Radiopharmaceutical Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Nuclear Radiopharmaceutical Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Nuclear Radiopharmaceutical Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Nuclear Radiopharmaceutical Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Nuclear Radiopharmaceutical Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Nuclear Radiopharmaceutical Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Nuclear Radiopharmaceutical Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Nuclear Radiopharmaceutical Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Nuclear Radiopharmaceutical Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Nuclear Radiopharmaceutical Sales Volume by Application: 2019 VS 2023 VS 2030 (Units)
Table 34. Global Nuclear Radiopharmaceutical Sales Volume by Application (2019-2024) & (Units)
Table 35. Global Nuclear Radiopharmaceutical Sales Volume by Application (2025-2030) & (Units)
Table 36. Global Nuclear Radiopharmaceutical Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Nuclear Radiopharmaceutical Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Nuclear Radiopharmaceutical Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Nuclear Radiopharmaceutical Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Nuclear Radiopharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Nuclear Radiopharmaceutical Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Nuclear Radiopharmaceutical Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Nuclear Radiopharmaceutical Sales Value by Region (2019-2024) & (%)
Table 44. Global Nuclear Radiopharmaceutical Sales Value by Region (2025-2030) & (%)
Table 45. Global Nuclear Radiopharmaceutical Sales Volume by Region (Units): 2019 VS 2023 VS 2030
Table 46. Global Nuclear Radiopharmaceutical Sales Volume by Region (2019-2024) & (Units)
Table 47. Global Nuclear Radiopharmaceutical Sales Volume by Region (2025-2030) & (Units)
Table 48. Global Nuclear Radiopharmaceutical Sales Volume by Region (2019-2024) & (%)
Table 49. Global Nuclear Radiopharmaceutical Sales Volume by Region (2025-2030) & (%)
Table 50. Global Nuclear Radiopharmaceutical Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Nuclear Radiopharmaceutical Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Nuclear Radiopharmaceutical Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Nuclear Radiopharmaceutical Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Nuclear Radiopharmaceutical Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Nuclear Radiopharmaceutical Sales Volume, (2019-2024) & (Units)
Table 56. Key Countries/Regions Nuclear Radiopharmaceutical Sales Volume, (2025-2030) & (Units)
Table 57. Nihon Medi-Physics Co.,Ltd. Company Information
Table 58. Nihon Medi-Physics Co.,Ltd. Introduction and Business Overview
Table 59. Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Product Offerings
Table 61. Nihon Medi-Physics Co.,Ltd. Recent Development
Table 62. Curium Pharma Company Information
Table 63. Curium Pharma Introduction and Business Overview
Table 64. Curium Pharma Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Curium Pharma Nuclear Radiopharmaceutical Product Offerings
Table 66. Curium Pharma Recent Development
Table 67. Cardinal Health Company Information
Table 68. Cardinal Health Introduction and Business Overview
Table 69. Cardinal Health Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Cardinal Health Nuclear Radiopharmaceutical Product Offerings
Table 71. Cardinal Health Recent Development
Table 72. Bayer Global Company Information
Table 73. Bayer Global Introduction and Business Overview
Table 74. Bayer Global Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Bayer Global Nuclear Radiopharmaceutical Product Offerings
Table 76. Bayer Global Recent Development
Table 77. GE Healthcare Company Information
Table 78. GE Healthcare Introduction and Business Overview
Table 79. GE Healthcare Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. GE Healthcare Nuclear Radiopharmaceutical Product Offerings
Table 81. GE Healthcare Recent Development
Table 82. Mallinckrodt Pharmaceuticals Company Information
Table 83. Mallinckrodt Pharmaceuticals Introduction and Business Overview
Table 84. Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Product Offerings
Table 86. Mallinckrodt Pharmaceuticals Recent Development
Table 87. Bracco Group Company Information
Table 88. Bracco Group Introduction and Business Overview
Table 89. Bracco Group Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Bracco Group Nuclear Radiopharmaceutical Product Offerings
Table 91. Bracco Group Recent Development
Table 92. Advanced Molecular-imaging Solution Company Information
Table 93. Advanced Molecular-imaging Solution Introduction and Business Overview
Table 94. Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Product Offerings
Table 96. Advanced Molecular-imaging Solution Recent Development
Table 97. China Isotope & Radiation Company Information
Table 98. China Isotope & Radiation Introduction and Business Overview
Table 99. China Isotope & Radiation Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. China Isotope & Radiation Nuclear Radiopharmaceutical Product Offerings
Table 101. China Isotope & Radiation Recent Development
Table 102. Ciaeriar Company Information
Table 103. Ciaeriar Introduction and Business Overview
Table 104. Ciaeriar Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Ciaeriar Nuclear Radiopharmaceutical Product Offerings
Table 106. Ciaeriar Recent Development
Table 107. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Information
Table 108. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Introduction and Business Overview
Table 109. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Product Offerings
Table 111. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Nuclear Radiopharmaceutical Downstream Customers
Table 115. Nuclear Radiopharmaceutical Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Radiopharmaceutical Product Picture
Figure 2. Global Nuclear Radiopharmaceutical Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Nuclear Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Nuclear Radiopharmaceutical Sales Volume (2019-2030) & (Units)
Figure 5. Global Nuclear Radiopharmaceutical Sales Price (2019-2030) & (US$/Unit)
Figure 6. Nuclear Radiopharmaceutical Report Years Considered
Figure 7. Global Nuclear Radiopharmaceutical Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Nuclear Radiopharmaceutical Players Sales Volume Ranking (2023) & (Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Nuclear Radiopharmaceutical Revenue in 2023
Figure 10. Nuclear Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Diagnostic Picture
Figure 12. Therapeutic Picture
Figure 13. Global Nuclear Radiopharmaceutical Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Nuclear Radiopharmaceutical Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Nuclear Radiopharmaceutical Sales Volume by Type (2019 VS 2023 VS 2030) & (Units)
Figure 16. Global Nuclear Radiopharmaceutical Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Nuclear Radiopharmaceutical Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Oncology
Figure 19. Product Picture of Thyroid
Figure 20. Product Picture of Cardiology
Figure 21. Product Picture of Others
Figure 22. Global Nuclear Radiopharmaceutical Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Nuclear Radiopharmaceutical Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Nuclear Radiopharmaceutical Sales Volume by Application (2019 VS 2023 VS 2030) & (Units)
Figure 25. Global Nuclear Radiopharmaceutical Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Nuclear Radiopharmaceutical Price by Application (2019-2030) & (US$/Unit)
Figure 27. North America Nuclear Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Nuclear Radiopharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Nuclear Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Nuclear Radiopharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Nuclear Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Nuclear Radiopharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Nuclear Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Nuclear Radiopharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Nuclear Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Nuclear Radiopharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Nuclear Radiopharmaceutical Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Nuclear Radiopharmaceutical Sales Volume (%), (2019-2030)
Figure 39. United States Nuclear Radiopharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Nuclear Radiopharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Nuclear Radiopharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Nuclear Radiopharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 45. China Nuclear Radiopharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 47. China Nuclear Radiopharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Nuclear Radiopharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Nuclear Radiopharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Nuclear Radiopharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Nuclear Radiopharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Nuclear Radiopharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Nuclear Radiopharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 57. India Nuclear Radiopharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 59. India Nuclear Radiopharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 60. Nuclear Radiopharmaceutical Industrial Chain
Figure 61. Nuclear Radiopharmaceutical Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed